IRONWOOD PHARMACEUTICALS, INC.

IRWD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K May 7, 2026 FORM 8-K
ARS Apr 28, 2026 ARS
DEFA14A Apr 28, 2026 DEFA14A
DEF 14A Apr 28, 2026 DEF 14A
SCHEDULE 13G/A Apr 27, 2026
SCHEDULE 13G/A Mar 27, 2026
SCHEDULE 13D/A Mar 19, 2026
4 Mar 17, 2026 4
4 Mar 12, 2026 4
4 Mar 12, 2026 4
4 Mar 12, 2026 4
4 Mar 12, 2026 4
4 Mar 12, 2026 4
4 Mar 12, 2026 4
8-K Mar 11, 2026 FORM 8-K
10-K Feb 26, 2026 10-K
4 Feb 25, 2026 4
4 Feb 25, 2026 4
4 Feb 25, 2026 4
4 Feb 25, 2026 4
4 Feb 25, 2026 4
4 Feb 25, 2026 4
8-K Feb 25, 2026 FORM 8-K
144 Feb 20, 2026
144 Feb 20, 2026
← Newer Page 2 of 58 · 1427 filings Older →